Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arcus Biosciences Inc (NY: RCUS ) 15.81 +0.83 (+5.54%) Official Closing Price Updated: 7:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Arcus Biosciences Inc < Previous 1 2 3 4 5 Next > Arcus Biosciences Announces New Employment Inducement Grants August 10, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights August 05, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences to Participate at the 2021 Wedbush PacGrow Virtual Healthcare Conference August 04, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights July 29, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants July 26, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants July 12, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 24, 2021 From Arcus Biosciences Via Business Wire Anti-TIGIT Domvanalimab-Based Combinations Showed Encouraging Clinical Activity in People with Metastatic, PDL1-High Non-Small Cell Lung Cancer at First Interim Analysis of Arcus Biosciences’ Randomized Phase 2 ARC-7 Study June 23, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants June 09, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants May 25, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences Presents Early Data from ARC-6, a Phase 1b/2 Study Evaluating Etrumadenant-Based Combinations in Metastatic Castrate-Resistant Prostate Cancer at the 2021 ASCO Annual Meeting May 19, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants May 11, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights May 05, 2021 From Arcus Biosciences Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants April 26, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting April 10, 2021 From Arcus Biosciences, Inc. Via Business Wire Arcus Biosciences Announces New Employment Inducement Grants April 09, 2021 From Arcus Biosciences Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.